While incretins have significant and widespread impacts on different organs, their actions are not long-lasting
Some patients use compounding pharmacies to obtain cheaper semaglutide formulations, but a 2025 FDA mandate largely shut down the bulk compounding of GLP-1s ( [18] ) ( [64] )
The Noom Proactive Health GLP-1 Program monitors 17 key biomarkers that directly impact metabolic function, heart health, inflammation, and hormonal balance
Furthermore, patients who responded well to initial lower doses were often titrated to higher doses for sustained and enhanced results, reinforcing the growth of the segment
The FDA-approved products have the advantage of consistent quality, established supply chains, and comprehensive safety monitoring